Clinical Trial Update: Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of vasopressin, methylprednisolone, and epinephrine for in-hospital cardiac arrest has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-hospital Cardiac Arrest

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)
• METHYLPREDNISOLONE (methylprednisolone)
• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: University of Athens | Conditions: Heart Arrest | Phase 2 | Status: COMPLETED